Cargando…
Betaxolol as a Potent Inhibitor of NDM-1-Positive E. coli That Synergistically Enhances the Anti-Inflammatory Effect in Combination with Meropenem
With significant human and economic losses, increasing bacterial resistance is a serious global threat to human life. Due to their high efficacy, broad spectrum, and cost-effectiveness, beta-lactams are widely used in the clinical management of bacterial infection. The emergence and wide spread of N...
Autores principales: | Sun, Jichao, Ren, Shangjie, Yang, Yaozu, Li, Xiaoting, Zhang, Xiuying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487625/ https://www.ncbi.nlm.nih.gov/pubmed/37686201 http://dx.doi.org/10.3390/ijms241713399 |
Ejemplares similares
-
Enzyme Inhibitors: The Best Strategy to Tackle Superbug NDM-1 and Its Variants
por: Li, Xiaoting, et al.
Publicado: (2021) -
Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring bla(NDM-1) and bla(NDM-5)
por: Terbtothakun, Pawarisa, et al.
Publicado: (2021) -
Specific NDM-1 Inhibitor of Isoliquiritin Enhances the Activity of Meropenem against NDM-1-positive Enterobacteriaceae in vitro
por: Wang, Yanling, et al.
Publicado: (2020) -
Influence of Betaxolol on the Methamphetamine Dependence in Mice
por: Kim, Byoung-Jo, et al.
Publicado: (2016) -
Direct Enantiomeric Resolution of Betaxolol with Application to Analysis of Pharmaceutical Products
por: Hefnawy, Mohamed M., et al.
Publicado: (2007)